製品の概要

  • 製品名DAPTA
  • 製品の詳細
    Potent, selective CCR5 antagonist
  • 生理活性の詳細Potent, selective CCR5 antagonist. Synthetic peptide. Selective antiviral entry inhibitor for R5 tropic HIV-1 isolates. Able to attenuate neuroinflammation.
  • 精製度> 95%

製品の特性

    DAPTA (ab120810) 使用論文

    This product has been referenced in:
    • Di Prisco S  et al. RANTES-mediated control of excitatory amino acid release in mouse spinal cord. J Neurochem 121:428-37 (2012). Read more (PubMed: 22385043) »
    • Pollicita M  et al. Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells. Antivir Chem Chemother 18:285-95 (2007). Read more (PubMed: 18046961) »
    • Polianova MT  et al. Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA). Antiviral Res 67:83-92 (2005). Read more (PubMed: 16002156) »
    • Rosi S  et al. Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease. Neuroscience 134:671-6 (2005). Read more (PubMed: 15979806) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120810.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"